Loading clinical trials...
Loading clinical trials...
A Long-term, Multicentre, Double-blind, Randomised Parallel-group Trial to Determine Whether Reducing Post-prandial Glycaemia Can Reduce Cardiovascular-related Morbidity and Mortality in Patients With Established Coronary Heart Disease or Acute Coronary Syndrome Who Have Impaired Glucose Tolerance
Conditions
Interventions
Acarbose
Matching Placebo
Locations
177
China
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Beijing Chuiyangliu Hospital
Beijing, Beijing Municipality, China
China Meitan General Hospital
Beijing, Beijing Municipality, China
Beijing Anzhen Hospital of The Capital University of Medical Sciences
Beijing, Beijing Municipality, China
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Peking University First Hospital
Beijing, Beijing Municipality, China
Start Date
February 17, 2009
Primary Completion Date
April 11, 2017
Completion Date
April 18, 2017
Last Updated
July 25, 2017
NCT07436429
NCT07429227
NCT01311323
NCT06543082
NCT06535568
NCT07032389
Lead Sponsor
University of Oxford
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions